Close

content

ViGeneron and WuXi AppTec Enter Strategic Manufacturing Partnership for Next-Generation Ophthalmic Gene Therapy

ViGeneron, a gene therapy company, and WuXi Advanced Therapies Inc. (WuXi ATU), a leading Contract, Testing, Development and Manufacturing Organization (CTDMO), announced a strategic...

Ufovax extends IP portfolio to include patent covering the design of an optimized antigen for COVID-19

Ufovax, a vaccine biotechnology company, has extended its intellectual property portfolio to include an exclusive global license to a patent covering the design of...

BD to Invest $1.2 Billion in Pre-Fillable Syringe Manufacturing Capacity Over Next Four Years

BD, a leading global medical technology company, announced plans to invest approximately $1.2 billion over a 4-year period to expand and upgrade manufacturing capacity...

New destinations for life-saving pharmaceutical products

DoKaSch Temperature Solutions and Air Europa have signed a Master Rental Agreement about the usage of the temperature-controlled Opticooler packaging solution. The collaboration opens...

UK Approves Pfizer COVID-19 Vaccine: Expect A Next Week Roll-Out

In a historic occurrence which has taken the world by storm, the UK Government has officially approved the usage of Pfizer’s coronavirus vaccine. This...

Biopharma Market Worth $546.6 billion by 2027

Biopharma market was valued at approximately USD 244.1 Billion in 2019 and is expected to generate revenue of around USD 546.6 Billion by end...

Vaccine nationalism, CDMO expansion, AMR and dual sourcing predicted in 2021 according to new CPhI Report

A new report from CPhI explores the potential implications in 2021 of impending vaccine approvals, a new administration in the White House and a...

Subscribe

- Never miss a story with notifications

- Gain full access to our premium content

- Browse free from up to 5 devices at once

Must read